Table 4.
Univariate |
Multivariate |
|||||
---|---|---|---|---|---|---|
HR | 95% CI | p values | HR | 95% CI | p values | |
Male | 5.19 | 1.04–25.83 | 0.0445 | |||
Age ≥60 years | 15.5 | 1.81–132.7 | 0.0124 | 20.78 | 1.86–231.86 | 0.0137 |
Tumor >4 cm | 3.84 | 0.77–19.03 | 0.0995 | |||
Ex2 | 12.1 | 1.41–103.4 | 0.0231 | 13.98 | 1.29–151.66 | 0.0301 |
cN1b | 6.44 | 1.18–35.2 | 0.0315 | 5.18 | 0.88–33.55 | 0.0844 |
Ml | 7.28 | 0.845–62.87 | 0.0709 | 9.42 | 0.60–148.37 | 0.1108 |
Aggressive type | 5.57 | 1.12–27.7 | 0.0359 | |||
Ki-67 LI >10% | 23.58 | 4.31–128.94 | 0.0003 | 34.08 | 3.81–305.16 | 0.0016 |
Ki-67 LI 5–10% | 1.28 | 0.149–11.01 | 0.8210 | |||
Biochemically PD | NC | NC | NC | excluded | ||
Tg-DT ≤2 years | NC | NC | NC | excluded |
HR = Hazard ratio; CI = confidence interval; Ex2 = significant extrathyroid extension; Biochemically PD = biochemically persistent disease; Tg-DT = thyroglobulin doubling time. NC = Not calculated because all of the patients who died of the cancer had biochemically PD and Tg-DT <2 years. For the multivariate analysis, these two factors were excluded from the analysis.